NCT05823844 Efficacy of Suvorexant on Post-operative Sleep Disturbance Status RECRUITING Phase PHASE4
NCT05822193 Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil Status RECRUITING Phase N/A
NCT05818137 A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020) Status COMPLETED Phase PHASE3
NCT05818124 Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019) Status COMPLETED Phase PHASE1
NCT05815927 Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer Status RECRUITING Phase PHASE3
NCT05813223 Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough Status RECRUITING Phase EARLY_PHASE1
NCT05806138 A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05789615 Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China Status COMPLETED Phase N/A
NCT05787587 A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05784688 Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05782361 POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05775549 A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer Status COMPLETED Phase N/A
NCT05775471 Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer Status RECRUITING Phase PHASE2
NCT05769595 Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) Status COMPLETED Phase PHASE1
NCT05767138 STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012 Status COMPLETED Phase N/A
NCT05766501 A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05766371 Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT05763823 A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045) Status COMPLETED Phase PHASE3
NCT05763004 A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05761951 Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2